Mashiripiti emagetsi munda wekurapwa kwehuropi bundu

Mashiripiti emagetsi munda wekurapwa kwehuropi bundu, iyo Yakanyanya kurapwa kwehuropi bundu munyika. Mutengo wemashiripiti emagetsi munda kurapa pakurapa kwehuropi tumarara varwere. Mutengo wehuropi tumarara kurapwa.

Share This Post

Pane zvichangobva kuitika pamashiripiti emagetsi ekurapa bundu reuropi.

Glioblastoma chirwere chinouraya chinonzi "terminator" nekuti bundu iri rinokura nekukurumidza uye rinogona kubata chero wezera ripi zvaro, riine fungidziro yakaipa.

There is currently no cure for this tumor, and treatment is difficult because glioblastomas extend the antennae into the brain instead of forming a solid mass that a doctor can target and remove. So even if the surgical resection is clean, the average time to tumarara recurrence is only 6.9 months, and the average survival time is only 14.6 months. During the treatment process, resistance to traditional treatment is prone to occur. What is more frightening is that this kind of Tumors have a curse that has a nearly 100% chance of recurrence.

Prelude kune Anouya Dhiyabhorosi-Zvishoma nezvishoma Tenderedza Muviri Wako

Scott Rider ane makore makumi matanhatu nerimwe anogara muWilliamsport. Akarega basa uye anogara nemukadzi wake nehama yake, uye ane muzukuru akanaka.

Rimwe zuva, aiwacha ndokuona kuti muviri wake wairatidza kuramba wakatsamira kusvika apinda musinki zvishoma nezvishoma…

Aisaziva zvaitika, asi mazuva mashoma akatevera zvinhu zvakawedzera kuipa. Akatanga kunzwa kuneta zvakanyanya, kunyangwe dai asina kuita chero chinhu, uye akaneta zvakanyanya.

The family was a little worried whether it would be Alzheimer’s disease. He accompanied him to the hospital for a systematic examination. After the diagnosis, the whole family was shocked. Rider got one of the most deadly uropi hwehuropi, glioblastoma, but The predicted life can only be calculated in months, not years.

Muna Kubvumbi 2017, achitsigirwa nemhuri yake, akavhiyiwa. Chiremba akataura kuti pari zvino maronda akachekwa akachena, asi kufa kwebundu rehuropi uku ndiko kuti zvichadzoka zvakare, asi nekukurumidza kana gare gare dambudziko, saka zvakadaro Unoda kugamuchira radiotherapy uye chemotherapy nekukurumidza sezvinobvira kuuraya zvakasara. masero egomarara mumuviri kusvika pamwero mukuru uye kunonoka kudzoka zvakanyanya sezvinobvira.

"Mashiripiti" munda wemagetsi-simudza mashiripiti ekudzokazve

Munguva yekemotherapy, chiremba anorapa waRider akati iyo FDA ikozvino yabvumidza nzira nyowani yekurapa, yemagetsi Therap kurapwa, inozivikanwawo seOptune, ine ina ma electrode mapedhi akasungirirwa kumurwere akaveurwa ganda romusoro. Inogadzira yakadzika-yakasimba, yakaderera-frequency magetsi munda iyo inopfuudzwa neiyo transducer rongedzo kunzvimbo yeiyo glioblastoma bundu.

Electric fields can destroy rapidly dividing cancer cells, especially gliomas, a type of tumor that divides rapidly.

VaRider vanoshandisa MRI kuongorora mapundu europi mimwe mwedzi yega yega. Iye akati, “Muchiitiko chakanakisisa, raizodzikira, asi kwandiri harina kuzokura zvakare, rakanga rakatsiga zvikuru, izvo zvakanga zvakanaka zvikuru.

Iye zvino, Mutasvi anotenda kuti munda wemagetsi ne "masimba emashiripiti" ari kusimudza kutuka kunowanzoitika kwaari, uye ndiye "anobatsira" anoponesa hupenyu.

Anorangarira kuti paakatanga kuongorora glioblastoma, vanachiremba vakati aingova nemwedzi gumi nemasere kusvika makumi maviri nemana yehupenyu. Nekudaro, ikozvino wave mwedzi wechi18 mushure mekuvhiyiwa, uye hapana zviratidzo zvekudzokazve, akati anogara achipfeka munda wemagetsi kuti ugone kuramba uchishanda.

Kana VaRider vasingade basa, vanoita mimwe mitambo yavo yavanofarira, senge kutsetsereka uye hockey. Paaive pamba, akatambawo nemuzukuru wake akanaka. Ndiwo mashiripiti emagetsi ekurapa. Iyo inokutendera iwe kudzora gomarara maseru mumuviri wako pasi pemamiriro ehupenyu hwakazara zvachose. Masero nevanhu vakavakomberedza vane mhedzisiro yakaipa.

Mr. Mutasvi anotarisira kuti kubudirira kwake kuchapa tariro kune vamwe. "Handina nzira yekukunda nayo bundu rinouraya kunge bundu muuropi, asi ndinogona kurarama nenzira yakanaka."

Electric field therapy-FDA-inogamuchirwa nyowani yekurapa tekinoroji

Optune yakagamuchirwa neDFA uye yakafukidzwa neakawanda inshuwarisi.

 

Electric field therapy ikozvino inogamuchirwa neDFA ye:

1. Treatment of adult patients with unresectable, locally advanced or metastatic mesothelioma (MPM), can be used with pemetrexed and platinum chemotherapy.

2. Adult patients (22 years or older) for histologically confirmed glioblastoma multiform (GBM).

3. Yakasanganiswa temozolomide yekurapa glioblastoma ichangobva kuongororwa muvarwere vakuru.

4. Kune anodzokororazve maglioma mushure mekugamuchira chemotherapy, magetsi ekurapa anogona kugamuchirwa ari ega.

The use of alternating low-intensity electric fields can destroy tumor cells and reduce damage to healthy tissues, which can effectively prevent side effects from affecting patients’ quality of life. Since 2000, the R & D team has been developing and expanding indications for electric field therapy. At present, researchers are conducting clinical trials on common solid tumors, including non-small cell lung cancer, non-small cell lung cancer brain metastasis, pancreatic cancer has launched phase III clinical trials, ovarian kenza and mesothelioma have completed phase II clinical trials, will soon Entered Phase III trials, and liver cancer is undergoing Phase II trials. These cancers have achieved very exciting clinical data.

Bundu rinorapa magetsi munda Optune ibasa nyowani rerapa kurapwa chirongwa. Uku ndiko kurapwa kunoshandisa yakatarwa magetsi yemagetsi frequency kukanganisa kupatsanurwa kwemasero, kutadzisa kukura kwechirwere uye kukonzera maseru egomarara akanganiswa nemunda wemagetsi kufa. In vitro uye in vivo zvidzidzo zvakasimbisa kuti bundu rinorapa emagetsi minda inogona kunonoka uye kudzosera bundu kukura nekudzivirira mitosis yemamota maseru.

Anonyanya kuzivikanwa hura huro nyanzvi Dr. Roger Stupp akamboti:

“Makore makumi maviri apfuura, pandakatanga kurapa glioblastoma, varwere vakawanda vakafa mugore risingasviki, uye pakanga pasina nyaya dzokurarama kwenguva refu. Sezvo tumor mumunda kurapwa kwakasanganiswa ne temozolomide kurapwa, varwere ve7 Mumwe wavo akararama anopfuura makore mashanu. “

Uye zvakare, mhedzisiro yebundu remagetsi kurapwa kurapwa kwakabatana zvakanyanya nekuteerera. Kana varwere vakapfeka anopfuura maawa makumi maviri nemaviri pazuva, makore mashanu ekupona anogona kuwedzera kusvika pa22%, ino ingangoita kakapetwa ka29.3 makore mashanu ekupona kwetemozolomide chete! Zvinotonyanya kukosha, iyi nzira yekurapa haina kana mhedzisiro inokonzerwa nekemoradiation. Inowanzozivikanwa ndeyekuputika pane iyo electrode pad yekubata nzvimbo. Izvi zvisati zvamboitika munhoroondo yehuropi bundu kurapwa.

Zvinonzi Zaiding Pharmaceuticals iri kuendesa chikumbiro chemvumo yakakosha yezvishandiso zvekurapa kuHurumende yeDrug Administration, uye inoronga kuendesa chikumbiro chemagetsi emumunda kuti asunungurwe kumiedzo yekiriniki. Panguva imwecheteyo, yakapedza kubhadharazve US $ 200 mamiriyoni. Yakaunzwa Optune, bundu electric field therapy, kutanga nguva itsva yeasina-invasive bundu kurapwa! Parizvino, unogona kuenda kuHong Kong kuburikidza neDhipatimendi Rezvokurapa reGlobal Oncologist Network, uye ugamuchire kurapwa kwemagetsi mumunda muJapan (400-666-7998)

I look forward to electric field therapy entering mainland China as soon as possible, and hope that this technology that brings huge survival benefits to cancer patients can enter medical insurance as soon as possible and bring the gospel to the majority of patients!

 

Zvinyorwa: https://www.pahomepage.com/news/using-electricity-to-treat-aggressive-brain-tumor/

 

 

 

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kurapa Kwemasero eCAR T kunoitwa nevanhu: Kubudirira Uye Zvinetso
CAR T-Cell kurapa

Kurapa Kwemasero eCAR T: Kubudirira uye Zvinetso

Human-based CAR T-cell therapy inosandura kurapwa kwegomarara nekugadzirisa magene masero emuviri emurwere kuti anange nekuparadza maseru egomarara. Nekushandisa simba rekudzivirira kwemuviri, marapirwo aya anopa marapiro ane simba uye emunhu ane mukana wekuregererwa kwenguva refu mumhando dzakasiyana dzegomarara.

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa